← Open Payments lookup

JANAK MEHTANI: Open Payments

NPI 1477581106 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,784 in 21 payments from 9 companies in 2025. Trend: 2023 $1,748 · 2024 $1,626 · 2025 $1,784

Food & beverage: $1,784
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$538
Otsuka America Pharmaceutical, Inc.5$374
E.R. Squibb & Sons, L.L.C.2$249
Teva Pharmaceuticals USA, Inc.2$137
Janssen Pharmaceuticals, Inc1$126
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Alkermes, Inc.2$124
Luye Pharma (USA) Ltd.1$97
ABBVIE INC.1$14

Products named: INGREZZA, REXULTI, COBENFY, INVEGA SUSTENNA, CAPLYTA, ARISTADA, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.